PUBLICATION

Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility

Authors
Endo, Y., Groom, L., Celik, A., Kraeva, N., Lee, C.S., Jung, S.Y., Gardner, L., Shaw, M.A., Hamilton, S.L., Hopkins, P.M., Dirksen, R.T., Riazi, S., Dowling, J.J.
ID
ZDB-PUB-220615-1
Date
2022
Source
Nature communications   13: 3403 (Journal)
Registered Authors
Dowling, Jim
Keywords
none
MeSH Terms
  • Animals
  • Caffeine/pharmacology
  • Calcium-Binding Proteins
  • Heat Stress Disorders*
  • Humans
  • Malignant Hyperthermia*/genetics
  • Membrane Proteins
  • Mixed Function Oxygenases
  • Muscle Contraction
  • Muscle Fibers, Skeletal
  • Muscle Proteins
  • Zebrafish/genetics
PubMed
35697689 Full text @ Nat. Commun.
Abstract
Exertional heat illness (EHI) and malignant hyperthermia (MH) are life threatening conditions associated with muscle breakdown in the setting of triggering factors including volatile anesthetics, exercise, and high environmental temperature. To identify new genetic variants that predispose to EHI and/or MH, we performed genomic sequencing on a cohort with EHI/MH and/or abnormal caffeine-halothane contracture test. In five individuals, we identified rare, pathogenic heterozygous variants in ASPH, a gene encoding junctin, a regulator of excitation-contraction coupling. We validated the pathogenicity of these variants using orthogonal pre-clinical models, CRISPR-edited C2C12 myotubes and transgenic zebrafish. In total, we demonstrate that ASPH variants represent a new cause of EHI and MH susceptibility.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping